Physician profile
Mark E Hollingshead
NPI 1689670911
$3,431.96
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $262 · 2021: $564 · 2022: $519 · 2023: $529 · 2024: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995 · Long Term Medical Supply Or Device Loan: $191 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.06 |
| Long Term Medical Supply Or Device Loan | $191.46 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $675.30 | 2022-2024 | Stellaris, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $635.65 | 2019-2021 | |
| Alcon Vision LLC | $459.15 | 2019-2024 | Clareon, Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $359.82 | 2019-2023 | |
| Sight Sciences, INC. | $221.33 | 2021-2022 | |
| Rxsight INC | $202.53 | 2021-2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Carl Zeiss Meditec USA, INC. | $191.46 | 2023 | Cirrus Hd-Oct |
| Ivantis, INC | $180.49 | 2019-2021 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Glaukos Corporation | $89.11 | 2020 | |
| New World Medical,INC. | $80.95 | 2022 | |
| Abbvie INC. | $73.17 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $69.08 | 2019-2020 | |
| Horizon Therapeutics Plc | $55.97 | 2023 | Tepezza |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $16.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hollingshead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.